IGF2R antibody [MEM-238] (APC)
GTX79972
ApplicationsFlow Cytometry
Product group Antibodies
TargetIGF2R
Overview
- SupplierGeneTex
- Product NameIGF2R antibody [MEM-238] (APC)
- Delivery Days Customer9
- Application Supplier NoteFACS: 10 microl reagent / 100 microl of whole blood or 106 cells in a suspension. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsFlow Cytometry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDMEM-238
- ConjugateAPC (Allophycocyanin)
- Gene ID3482
- Target nameIGF2R
- Target descriptioninsulin like growth factor 2 receptor
- Target synonymsCD222, CI-M6PR, CIMPR, M6P-R, M6P/IGF2R, MPR 300, MPR1, MPR300, MPRI, cation-independent mannose-6-phosphate receptor, 300 kDa mannose 6-phosphate receptor, CI Man-6-P receptor, IGF-II receptor, M6P/IGF2 receptor, insulin-like growth factor II receptor
- HostMouse
- IsotypeIgG1
- Protein IDP11717
- Protein NameCation-independent mannose-6-phosphate receptor
- Scientific DescriptionThis gene encodes a receptor for both insulin-like growth factor 2 and mannose 6-phosphate. The binding sites for each ligand are located on different segments of the protein. This receptor has various functions, including in the intracellular trafficking of lysosomal enzymes, the activation of transforming growth factor beta, and the degradation of insulin-like growth factor 2. Mutation or loss of heterozygosity of this gene has been association with risk of hepatocellular carcinoma. The orthologous mouse gene is imprinted and shows exclusive expression from the maternal allele; however, imprinting of the human gene may be polymorphic, as only a minority of individuals showed biased expression from the maternal allele (PMID:8267611). [provided by RefSeq, Nov 2015]
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- The role of insulin-like growth factor in Acrochordon Etiopathology. Koeseoglu HG et al., 2020 Nov 3, BMC DermatolRead more
- Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. Koeberl DD et al., 2014 May, FASEB JRead more
- Adjunctive beta2-agonists reverse neuromuscular involvement in murine Pompe disease. Li S et al., 2013 Jan, FASEB JRead more
- Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle. Koeberl DD et al., 2011 Jun, Mol Genet MetabRead more

![FACS (intracellular staining) analysis of human peripheral blood using GTX28093-08 IGF2R antibody [MEM-238] (PE).](https://www.genetex.com/upload/website/prouct_img/normal/GTX28093-08/GTX28093-08_20191025_AP_006_203_w_23060722_726.webp)
![Fig. 1. Western Blotting analysis (non-reducing conditions) of CD222 in whole cell lysate of JURKAT human peripheral blood T cell leukemia cell line. Lane 1: immunostaining with anti-CD222 [MEM-238] Lane 2: immunostaining with Isotype mouse IgG1 control](https://www.genetex.com/upload/website/prouct_img/normal/GTX28093/IGF2-receptor-antibody-MEM-238-GTX28093-WB-1_w_23060722_830.webp)
![FACS analysis of HeLa cells using GTX64270 IGF2 Receptor antibody [GT1078]. Blue : Primary antibody Red : Isotype control](https://www.genetex.com/upload/website/prouct_img/normal/GTX64270/GTX64270_20180608_FACS_w_23061203_493.webp)
